Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Observational 4Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Lung Neoplasms 8Colorectal Neoplasms 4Stomach Neoplasms 3Rectal Neoplasms 3Prostatic Neoplasms 3Neoplasms 3Smoking Cessation 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Motor Activity 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Colonic Neoplasms 2Wilms Tumor 1Venous Thromboembolism 1Uveal Melanoma 1Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Opioid-Related Disorders 1Neuroblastoma 1Neoplastic Cells, Circulating 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Leukemia 1Inflammation 1Hodgkin Disease 1Hepatic Veno-Occlusive Disease 1HPV Positive Oropharyngeal Squamous Cell Carcinoma 1Fibrosis 1

Interventions

Docetaxel 277Prednisone 236enzalutamide 175Leuprolide 172Radiotherapy 164Abiraterone Acetate 153Magnetic Resonance Spectroscopy 147bicalutamide 137Goserelin 134Androgen Antagonists 111Radiosurgery 101acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100apalutamide 78abiraterone 75gallium 68 PSMA-11 74Specimen Handling 67Gonadotropin-Releasing Hormone 58darolutamide 56Radiation 56Triptorelin Pamoate 53cabazitaxel 49Zoledronic Acid 49pembrolizumab 48Radiotherapy, Intensity-Modulated 47Flutamide 47Brachytherapy 47luprolide acetate gel depot 46Standard of Care 45Carboplatin 44Estramustine 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Prostatic Neoplasms × Hematologic Tests × Clear all
NCT03568188 2026-02-24

FOCALE

Hospices Civils de Lyon

Phase 2 Completed
174 enrolled
Genitourinary

Prostatic Neoplasms

NCT02346526 2022-09-29

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

Massachusetts General Hospital

Phase 2 Completed
22 enrolled 14 charts
Genitourinary

Prostatic Neoplasms

NCT02747563 2016-04-21

Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination

Kaplan Medical Center

Phase 1 Unknown
60 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡